A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects - Concepedia

Concepedia

Publication | Closed Access

A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects

47

Citations

25

References

1997

Year

Barry Peters, R. Cheingsong‐Popov, David Callow, Russell B. Foxall, Gary Patou, K Hodgkin, Jonathan Weber

Journal of Infection

Primary ImmunodeficiencyMedicineImmunodeficienciesHuman RetrovirusImmunologyHivImmunotherapyHiv P17/p24Aids Pathogenesis

References

	Year	Citations

Page 1